Assessing the Impact of Aging on the Genetic Landscape of Advanced Breast Cancer
DESTINY-Gastric03: Analyzing Trastuzumab Deruxtecan for Gastric and GEJ Cancers
BREAKWATER Trial: Encorafenib Plus Cetuximab With FOLFIRI Shows Strong Efficacy in BRAF V600E-mutant mCRC